2Lister CA, Boam D, Bretherton-Wall D, et al. Rosiglitazone increases pancreatic islet area, number and insulin conteaat, but not insulin gene expression [ J ]. Diabetologhu, 1998, 41 ( Suppl ) :A660.
3Finegood DT, McArthur MD, Kojwang D, et al. The PPARγ ag-onist rosiglitazone(RSG) decreases net loss of pancreatic β-cell mass in Zucker diabetic rally rats[J ]. Diabetes, 1999; 48(Suppl) :$237.
4Spiegelman B M. PPAR-gamma:adipogenic regulator and thiazo-liadinedione receptor[J].Deabetes, 1998,47: 507.
5Oakes ND,Kennedy CJ,Jenkins ABet al. A new antidiabetic agent, BRL49653, reduces lipid availability and improves insulin action and glucoregulation in the rat [ J ]. Diabetes, 1994, 43:1203.
6Young PW, Cawthome MA, Coyle PJ, et al. Repeal treatment of obese mice with BTL496S3, a new potent insulin sensitizer, enhances insulin action in shite adipocyles, Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling [ J ]. Diabetes, 1995,44:1087.
